Harbor MedTech, Inc. – Trademark Portfolio
Entity Type: 03
Harbor MedTech, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include BRIDGE, BPMATRIX, ARCHITECT, and THE ONE AND DONE SOLUTION FOR COMPLEX WOUNDS. The owner is based in Irvine, CA.
4 Jenner, Suite 190
Irvine, CA 92618
Showing of trademarks Trademarks
Trademark Classifications
Harbor MedTech, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Harbor MedTech, Inc. have?
Harbor MedTech, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned, 1 cancelled.
What trademark classes does Harbor MedTech, Inc. file in?
Harbor MedTech, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Harbor MedTech, Inc.'s most well-known trademarks?
Harbor MedTech, Inc.'s registered trademark portfolio includes well-known marks such as BRIDGE, BPMATRIX, ARCHITECT, and THE ONE AND DONE SOLUTION FOR COMPLEX WOUNDS. These are among 4 currently registered trademarks in the portfolio.
What is Harbor MedTech, Inc.'s trademark registration success rate?
Harbor MedTech, Inc. has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.